Drug recall · October 2, 2019
Natpara recall
Why: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0203-02
- Lots / codes
06628461, exp 8/31/2020 06661658, 07110136, 7164106, 07761970 exp 10/31/2020 07630717, 08689119, exp 12/31/2020 07769458, exp 4/30/2021 07983643, 08003758, exp 6/30/2021 08214790, exp 8/31/2020 NY17002DA, NY17002DB, exp 6/30/2020
- Quantity
- 13,897
- Company
- Shire Human Genetic Therapies, Inc., Lexington, MA
- Distribution
- Product was distributed throughout the United States.
- Initiated
- September 12, 2019 · Voluntary: Firm initiated
- Classified
- October 1, 2019
- Reported
- October 2, 2019
- Ended
- March 23, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.